Moleculin Biotech, Inc. Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit: ratio: %
Description: Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary: Moleculin Biotech, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
Moleculin Biotech, Inc. Return On Assets for the quarter ending September 30, 2024 was -102 %, a 89.7% decline year-over-year.
Moleculin Biotech, Inc. annual Return On Assets for 2023 was -67.7 %, a 60.2% decline from 2022.
Moleculin Biotech, Inc. annual Return On Assets for 2022 was -42.2 %, a 143% decline from 2021.
Moleculin Biotech, Inc. annual Return On Assets for 2021 was -17.4 %, a 71.7% increase from 2020.

Return On Assets, Annual (%)

Return On Assets, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
2023	-67.7	-25.5	-60.2%	Jan 1, 2023	Dec 31, 2023
2022	-42.2	-24.9	-143%	Jan 1, 2022	Dec 31, 2022
2021	-17.4	+44.1	+71.7%	Jan 1, 2021	Dec 31, 2021
2020	-61.4	-12.9	-26.5%	Jan 1, 2020	Dec 31, 2020
2019	-48.6	+4.54	+8.55%	Jan 1, 2019	Dec 31, 2019
2018	-53.1	-5.07	-10.6%	Jan 1, 2018	Dec 31, 2018
2017	-48	-18.4	-62%	Jan 1, 2017	Dec 31, 2017
2016	-29.6			Jan 1, 2016	Dec 31, 2016

Showing 1 to 8 of 8 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.